Psychopharmacologic treatment of pediatric anxiety disorders.
This article reviews the psychopharmacologic treatment of child and adolescent anxiety disorders and is divided into the following sections: historical background, general treatment principles, obsessive-compulsive disorder, other anxiety disorders, including separation anxiety disorders, generalized anxiety disorder, and social phobia, elective mutism, and post-traumatic stress disorder and specific phobia. Short-term and long-term psychopharmacologic treatment strategies are reviewed, as are approaches for managing comorbidity and treatment-refractory cases. This article is organized by diagnostic categories rather than by medication classes to emphasize the clinical perspective.
Reinblatt
Shauna P
SP
Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. sreinbl1@jhmi.edu
Walkup
John T
JT
D000293:Adolescent; D001008:Anxiety Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D002648:Child; D015897:Comorbidity; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000453:epidemiology / Q000628:therapy; D013313:Stress Disorders, Post-Traumatic / Q000453:epidemiology / Q000628:therapy